Improving patient access to gynecologic cancer trials at UVA
Official title: Enhancing accrual across gynecologic and solid tumor trials
Funded at University of Virginia · NIH-11395537 · Data updated 2026-11-12
This grant helps UVA boost enrollment in gynecologic and solid tumor trials so more women with gynecologic cancers can access cutting-edge therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project start | September 1, 2024 |
| Project end | August 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $135,573 |
| NIH project number | 5R50CA285360-03 |
| Project ID | NIH-11395537 on NIH RePORTER |
Who could benefit from this research
✓Could help
Women with gynecologic cancers treated or seeking care at the UVA Comprehensive Cancer Center who may be eligible for clinical trials.
✕Less likely to help
Patients not currently eligible for trials or not interested in trial participation may not benefit.
What this research studies
The grant supports dedicating time to enhance clinical trial participation by removing barriers for patients and providers. It aims to grow participation in NCTN/ETCTN trials and strengthen UVA leadership in new studies. The effort includes building clinical research infrastructure and mentoring translational teams to accelerate trial availability for patients. It focuses on expanding accrual depth and breadth while maintaining high-quality care.
Why it matters
Potential benefit: Patients could gain faster access to new treatments and improved care through more available trials.
How similar studies have gone: Similar programs have shown that targeted trial-access initiatives can increase enrollment and access to experimental therapies.
Where this research is happening
-
University of Virginia
Charlottesville, United States Active
Researchers
- Principal investigator: Duska, Linda R — University of Virginia
- Study coordinator: Duska, Linda R
Related research
Other NIH-funded projects on the same topics.
-
Dual-targeted DOTA CAR T cells with image-guided monitoring for solid tumors
A Penn team is developing a controllable CAR T cell therapy for solid tumors that can be tracked with PET imaging and guided by targeted agents to improve safety and effectiveness.
-
Tuning CAR T cells to work better in solid tumors
A cancer-immunotherapy approach uses specially trained CAR T cells designed to attack solid tumors more effectively and safely.
-
A 3D lab tool to see how solid tumors squeeze and spread
This project builds a tiny 3D device that measures how solid tumors push, deform, and let cancer cells break away, which could help people with cancers that form solid tumors.
-
Dual-target CAR T therapy with PET tracking for solid tumors
A controllable CAR T-cell treatment that doctors can track with PET scans and direct at solid tumors in adults whose cancers express folate receptors.
-
Atlas of the tumor environment in childhood cancers
This project will map the cells and signals surrounding childhood solid tumors like neuroblastoma, rhabdomyosarcoma, and Wilms tumor to find weaknesses that could help children with high-risk disease.
-
KITv-enhanced CAR T cells for mesothelin-positive solid tumors
This work develops engineered CAR T cells that use a KITv switch to help treat people with mesothelin-expressing solid tumors, including pleural cancers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.